An Examination of New and Emerging Nonstatins
hosted byParadigm Medical Communications, LLCAn Examination of New and Emerging Nonstatins is organized by Paradigm Medical Communications, LLC.
Release Date: May 19, 2023
Expiration Date: May 19, 2024
Description:
Program Overview:
Recent releases of new clinical trial data for current nonstatins and new expert consensus treatment recommendations that target elevated levels of low-density lipoprotein cholesterol (LDL-C) can help inform decision-making and treatment selection. Explore these therapies for patients with hypercholesterolemia through an engaging and interactive infographic that illustrates clinical trial data and treatment approaches.
Learning Objectives:
Upon completion of this activity, participants should be able to:
• Describe clinical trial designs and the associated efficacy and safety data for newer and emerging LDL-C–lowering therapies
• Distinguish among the unique drug characteristics of newer and emerging nonstatin LDL-C therapies that may impact clinical decision-making
• Recognize the role of diet in patients with elevated LDL-C, including those currently prescribed pharmacotherapy
• Discuss the role of team-based care and shared decision-making in applying the guideline to various clinical practice settings
